Infographic: A Snapshot Of Non-Alcoholic Steatohepatitis R&D

Madrigal may gain the first NASH approval in early 2024; numerous candidates are lining up behind.

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.